Wei X, Zhao J, Nie L, Shi Y, et al. Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients. Prostate 2024 Oct 28. doi: 10.1002/pros.24809.
PMID: 39465570